Global Acromegaly Treatment Market Size (2024 - 2029)

The acromegaly treatment market is anticipated to experience growth due to several factors, including the rising prevalence of acromegaly and pituitary tumors, increased awareness of the disease, and advancements in drug development. The COVID-19 pandemic has also influenced the market, as patients with acromegaly may face heightened risks due to associated comorbidities, potentially driving demand for treatment. Despite these growth drivers, complications related to treatment pose challenges to market expansion.

Home Market Analysis Healthcare Research Pharmaceuticals Research Disease Specific Drugs Research Chronic Disorder Drugs Research Endocrinology Drugs Research Acromegaly Treatment Market Market Size

Market Size of Global Acromegaly Treatment Industry

acromegaly treatment 1
Study Period 2019 - 2029
Base Year For Estimation 2023
Forecast Data Period 2024 - 2029
CAGR 7.40 %
Fastest Growing Market Asia Pacific
Largest Market North America

Major Players

Global Acromegaly Treatment Market Major Players

*Disclaimer: Major Players sorted in no particular order

Acromegaly Treatment Market Analysis

The Acromegaly Treatment Market is expected to register a CAGR of 7.4% during the forecast period, 2022-2027.

The COVID-19 pandemic has significantly impacted acromegaly treatment. For instance, as per a November 2020 published article titled, "Growth hormone deficiency, acromegaly, and COVID-19: Transitioning from media reports to knowledge and a growth hormone hypothesis", having acromegaly does theoretically increase the risk of COVID-19 because of its associated comorbidities such as cardiovascular complications, diabetes mellitus, obstructive sleep apnea syndrome, chest wall deformity, upper airway obstruction, and intrathoracic collapse. Additionally, per a March 2021 published article titled, "Pituitary Disorders and COVID-19, Reimagining Care: The Pandemic A Year and Counting", patients with acromegaly have several characteristics that could potentially worsen their outcome if they develop COVID-19. Thus, such studies indicate that patients with COVID-19 disease are at high risk. Hence, the demand for acromegaly treatment is expected to increase in the near future.

Further, the significant factors contributing to the market's growth are the increasing prevalence and incidence of acromegaly and pituitary tumors; growing awareness regarding the disease worldwide; and technological advancements in developing new drugs for acromegaly.

The increasing prevalence of acromegaly and pituitary tumors is boosting the market growth. For instance, as per a May 2021 published article, "Descriptive Epidemiology and Survival Analysis of Acromegaly in Korea," the average annual incidence was 4.2 per million per year, and the prevalence was 32.1 cases per million during this period. Also, as per a July 2021 published article titled, "Global epidemiology of acromegaly: a systematic review and meta-analysis," the results revealed that out of a total of 32 studies included in the systematic review and 22 of them included in the meta-analysis, the pooled prevalence of acromegaly was 5.9 per 100,000 people. Moreover, as per a 2020 update by the Australian Pituitary Foundation, between 715 and 3,500 Australians currently live with acromegaly, representing around one person with acromegaly every 7,300 to 35,700 Australians. Thus, the statistics indicate that the demand for acromegaly treatment will increase shortly, thereby contributing to market growth.

However, complications associated with the treatment are a significant factor restraining the market's growth.

Acromegaly Treatment Industry Segmentation

As per the scope of the report, acromegaly is a rare acquired endocrine disease related to excessive growth hormone production and characterized by progressive somatic disfigurement (mainly involving the face and extremities) and systemic manifestations. The market is segmented By Product Type (Somatostatin Analogs, Growth Hormone Receptor Antagonist (GHRA), Dopamine Agonists, Other Product Types), and Geography(North America, Europe, Asia Pacific, Middle-East and Africa, and South America). The market report also covers the estimated market sizes and trends for 17 countries across major global regions. The report offers the value (USD million) for the above segments.

By Product Type
Somatostatin Analogs
Growth Hormone Receptor Antagonist (GHRA)
Dopamine Agonists
Other Product Types
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle-East and Africa
GCC
South Africa
Rest of Middle-East and Africa
South America
Brazil
Argentina
Rest of South America
Need A Different Region Or Segment?
Customize Now

Global Acromegaly Treatment Market Size Summary

The acromegaly treatment market is poised for substantial growth, driven by an increasing prevalence of acromegaly and pituitary tumors, heightened awareness of the disease, and advancements in drug development. The COVID-19 pandemic has underscored the importance of acromegaly treatment due to the heightened risk associated with comorbidities in affected patients. The market is characterized by a competitive landscape with key players such as Pfizer Inc., Novartis AG, and Ipsen, alongside emerging companies like Chiasma, Inc. and Crinetics Pharmaceuticals, which are actively developing innovative therapies. The introduction of novel treatments, such as the FDA-approved MYCAPSSA, highlights the ongoing advancements in the field, contributing to the market's expansion.

North America is anticipated to maintain a significant share of the global acromegaly treatment market, supported by the presence of leading pharmaceutical and biotech companies and a high demand for innovative treatment options. The market's growth is further bolstered by the increasing number of product approvals and the development of new therapeutic approaches, such as the oral somatostatin analogs. Despite the challenges posed by treatment complications, the market is expected to experience robust growth over the forecast period, driven by these dynamic developments and the ongoing efforts to improve patient outcomes.

Explore More

Global Acromegaly Treatment Market Size - Table of Contents

  1. 1. MARKET DYNAMICS

    1. 1.1 Market Overview

    2. 1.2 Market Drivers

      1. 1.2.1 Increasing Prevalence and Incidence of Acromegaly and Pituitary Tumors

      2. 1.2.2 Growing Awareness Regarding Acromegaly Disease Worldwide

      3. 1.2.3 Technological Advancements in Development of New Drugs for Acromegaly

    3. 1.3 Market Restraints

      1. 1.3.1 Complications Associated with the Treatment

    4. 1.4 Porter's Five Force Analysis

      1. 1.4.1 Threat of New Entrants

      2. 1.4.2 Bargaining Power of Buyers/Consumers

      3. 1.4.3 Bargaining Power of Suppliers

      4. 1.4.4 Threat of Substitute Products

      5. 1.4.5 Intensity of Competitive Rivalry

  2. 2. MARKET SEGMENTATION (Market Size by Value - USD million)

    1. 2.1 By Product Type

      1. 2.1.1 Somatostatin Analogs

      2. 2.1.2 Growth Hormone Receptor Antagonist (GHRA)

      3. 2.1.3 Dopamine Agonists

      4. 2.1.4 Other Product Types

    2. 2.2 Geography

      1. 2.2.1 North America

        1. 2.2.1.1 United States

        2. 2.2.1.2 Canada

        3. 2.2.1.3 Mexico

      2. 2.2.2 Europe

        1. 2.2.2.1 Germany

        2. 2.2.2.2 United Kingdom

        3. 2.2.2.3 France

        4. 2.2.2.4 Italy

        5. 2.2.2.5 Spain

        6. 2.2.2.6 Rest of Europe

      3. 2.2.3 Asia-Pacific

        1. 2.2.3.1 China

        2. 2.2.3.2 Japan

        3. 2.2.3.3 India

        4. 2.2.3.4 Australia

        5. 2.2.3.5 South Korea

        6. 2.2.3.6 Rest of Asia-Pacific

      4. 2.2.4 Middle-East and Africa

        1. 2.2.4.1 GCC

        2. 2.2.4.2 South Africa

        3. 2.2.4.3 Rest of Middle-East and Africa

      5. 2.2.5 South America

        1. 2.2.5.1 Brazil

        2. 2.2.5.2 Argentina

        3. 2.2.5.3 Rest of South America

Global Acromegaly Treatment Market Size FAQs

The Global Acromegaly Treatment Market is projected to register a CAGR of 7.40% during the forecast period (2024-2029)

Pfizer Inc, Ipsen, Chiasma, Inc, Validus Pharmaceuticals LLC and Novartis AG are the major companies operating in the Global Acromegaly Treatment Market.

Acromegaly Treatment Market Report Snapshots

Acromegaly Treatment Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)